Stock Events

Stock Events

Seres Therapeutics (MCRB) Q4 2024 Earnings

13NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.5

-0.14

0.22

0.58

Details

Expected EPS

-0.077531

Actual EPS

0.58

Surprise EPS

0.66

Surprise Percent

+848.09%

Description

Seres Therapeutics (MCRB) has reported earnings of 0.58 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.